CD274 and neoplasm: From inducing tumor cell apoptosis and reducing metastases to reprogramming macrophages, modulating Tregs, and suppressing PD-L1, BETi like i-BET151, ABBV-075, and JQ1 offer a comprehensive strategy to enhance antitumor immunity (Fig. 4).